The Mission Report

Noble Financial Capital Markets Conference

January 18th-21st, 2015
Sandpiper Bay, South Florida

Net Element, Inc. (NETE)

Net Element is a technology-driven group specializing in mobile payments and value-added transactional services that add convenience to mobile phone users’ lives and everyday commerce. The company’s innovations enable consumers to conduct commerce transactions from their mobile device, while online and offline payment capabilities allow merchants to reliably transact business anywhere and anyhow.

View Profile

Presenting Companies: A-G H-Z, Inc. (FLWS), Inc. (NASDAQ: FLWS) is a florist and gift shop offering a wide range of gifts such as fresh flowers and plants, gift baskets, gourmet foods, confections, candles, balloons, stuffed animals and more. The company also owns and operates BloomNet® international floral wire service, the Popcorn Factory®, Cheryl’s® cookies and baked gifts, Fannie May® confection brands, Stock Yards® steaks and chops,® and Celebrations® party store. For more information, visit the company’s website at

Actinium Pharmaceuticals, Inc. (ANTM)

Actinium Pharmaceuticals, Inc. (NYSE MKT: ANTM) is a biopharmaceutical company specializing in the development of cancer-related drugs. The company’s operations are currently focused on furthering development on leading drug candidates Actimab-A and lomab-B including moving forward with Phase I clinical trials and managing manufacturing. Following Phase II clinical trials, the company plans to partner drugs with an appropriate third party for completion of development and commercialization. For more information, visit the company’s website at

Advaxis, Inc. (ADXS)

Advaxis, Inc. (NASDAQ: ADXS) is a clinical-stage biotechnology company focusing on development of multiple cancer immunotherapies based on its proprietary cancer-fighting platform. The company has created and is developing more than 20 immunotherapies based on its platform, either directly or through collaboration. The company is currently conducting clinical trials with its leading product candidate, ADXS-HPV, in HPV-associated cervical cancer, head and neck cancer and anal cancer. For more information, visit the company’s website at

Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics, Inc. (NASDAQ: AGRX) is a pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Working to design products that provide women with greater convenience, the company’s leading product candidate Twirla®, a once-weekly contraceptive patch, is currently in Phase III clinical development. Using Skinfusion®, which is a proprietary transdermal patch technology, the company is designing a patch that optimizes adherence and patient acceptability. For more information, visit the company’s website at

Amarantus BioScience Holdings, Inc. (AMBS)

Amarantus BioScience Holdings, Inc. (NASDAQ: AMBS) is a biotechnology company developing treatments and diagnostics for diseases associated with endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis (programmed cell death). In addition to owning intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”), the company is also a founding member of the Coalition for Concussion Treatment, which raises awareness for concussions and nervous-system disorders. For more information, visit the company’s website at

American Shared Hospital Services (AMS)

American Shared Hospital Services (NYSE AMEX: AMS) is a healthcare company which focuses on leasing state-of-the-art radiosurgery and radiation therapy equipment to hospitals and medical centers. The company is the leader of Gamma Knife unit ownership in the United States, which is used for a non-invasive treatment of malignant and benign brain tumors, vascular malformations and facial pain. The company also offers the latest IGRT and IMRT systems. For more information, visit the company’s website at

Amtech Systems, Inc. (ASYS)

Amtech Systems, Inc. (NASDAQ: ASYS) is a manufacturer of capital equipment including silicon wafer handling automation, thermal processing and ion implant equipment and related consumables used in the fabrication processes of solar cells, LED and semiconductor devices. The company’s wafer handling, thermal processing and consumable products currently address the diffusion, oxidation and deposition steps used in the fabrication of solar cells, LEDs, semiconductors, MEMS and new sliced silicon wafer polishing. For more information, visit the company’s website at

Apollo Medical Holdings, Inc. (AMEH)

Apollo Medical Holdings, Inc. (OTC MKTS: AMEH) is a leading provider of physician-centric integrated healthcare management services which serves communities in California, Mississippi and Ohio. The company is addressing community healthcare needs by leveraging its integrated healthcare delivery platform, which is comprised of three affiliated and complementary physician groups. The company’s platform combines hospitalist medicine, critical care medicine, critical care medicine, case management and transition management, which enables performance payments for utilization efficiency. For more information, visit the company’s website at

Arch Therapeutics, Inc. (ARTH)

Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing a new approach to stopping bleeding (hemostasis) and controlling leaking (sealant) during surgery and trauma care. The company’s products in development are based on a self-assembling peptide technology platform designed to make surgery and interventional care faster and safer. The company’s flagship product candidate, AC5 Surgical Hemostatic Device, is designed to achieve hemostasis in minimally invasive and open surgical procedures. For more information, visit the company’s website at

Arno Therapeutics, Inc. (ARNI)

Arno Therapeutics, Inc. (OTC MKTS: ARNI) is a clinical stage biopharmaceutical company working to develop innovative products and next generation solutions for the treatment of cancer and other life threatening diseases. The company currently has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates, all of which are currently in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information, visit the company’s website at

Avino Silver & Gold Mines Ltd. (ASM)

Avino Silver & Gold Mines Ltd. (NYSE MKT: ASM) was founded in 1968 with a mission to create shareholder value through profitable, organic growth at the Avino property near Durango, Mexico and explore strategic acquisition options of mineral exploration and mining properties. The company is committed to maintaining an environmentally responsible, cost-effective method in regard to all business activities as well as contributing to the well-being of the communities in which the company operates. For more information, visit the company’s website at

Bacterin International Holdings, Inc. (BONE)

Bacterin International Holdings, Inc. (NYSE MKT: BONE) is a developer, manufacturer and marketer of biologics products to both domestic and international markets. The company’s products are used in a variety of applications including enhancing fusion in spinal surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. For more information, visit the company’s website at

Bioanalytical Systems, Inc. (BASI)

Bioanalytical Systems, Inc. (NASDAQ: BASI) is a pharmaceutical development company providing contract research services and monitoring instruments to some of the world’s leading drug development companies and medical research organizations. In addition to manufacturing more than 30 different scientific instruments, the company focuses on developing innovative new services and products designed to increase efficiency and reduce the costs associated with taking a new drug to market. For more information, visit the company’s website at

BioScrip, Inc. (BIOS)

BioScrip, Inc. (NASDAQ: BIOS) is a leading provider of infusion and home care management solutions. The company partners with physicians, hospital systems, facilities-based providers, healthcare payors and pharmaceutical manufacturers to provide patients with better access to post-acute care services. The company operates with a commitment to bringing customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. The company provides its services from over 75 locations across 29 states. For more information, visit the company’s website at

Brainstorm Cell Therapeutics, Inc. (BCLI)

Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a biotechnology company developing adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The company currently holds the rights to develop and commercialize its NurOwn™ technology through an exclusive agreement with the technology transfer company of Tel Aviv University, Ramot. NurOwn™ is currently being studied in a double-blind, placebo-controlled clinical trial in the United States. For more information, visit the company’s website at

Calpian, Inc. (CLPI)

Calpian, Inc. (OTCQB: CLPI) is a global mobile payments technology and processing company offering mobile payment services through Indian subsidiary Money-On-Mobile and domestic transaction services through Calpian Commerce. Money-On-Mobile enables Indian consumers to pay for goods and services or transfer funds from one cell phone to another through the use of simple SMS text functionality, while Calpian Commerce provides U.S. merchants with an integrated suite of payment processing services and related software products. For more information, visit the company’s website at

Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) is an advanced clinical stage drug development company with a platform technology that is designed to address the treatment of cancer and inflammatory diseases. The company’s CF101 is in Phase II/III trials for the treatment of psoriasis. CF102, the company’s liver cancer drug, is commencing Phase II trials and has been granted Orphan Drug Designation by the U.S. Food and Drug Administration. For more information, visit the company’s website at

Cancer Genetics, Inc. (CGIX)

Cancer Genetics, Inc. (NASDAQ: CGIX) is an emerging leader in DNA-based cancer diagnostics. The company’s tests target cancers that are difficult to diagnose, including hematological, urogenital and HPV-associated cancers. The company also offers a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professional and biopharma and biotech companies. The company has established strong research collaborations with major cancer centers throughout the U.S. For more information, visit the company’s website at

Churchill Downs, Inc. (CHDN)

Churchill Downs, Inc. (NASDAQ: CHDN) owns and operates the world-renowned Churchill Downs Racetrack, home of the Kentucky Derby and Kentucky Oaks, in addition to racetrack and casino operations in a variety of locations throughout the United States. The company also owns Big Fish Games, Inc., one of the world’s largest producers and distributors of casual games, and the premier online wagering company of the United States, For more information, visit the company’s website at

Ciber, Inc. (CBR)

Ciber, Inc. (NYSE: CBR) is a global IT consulting company with more than 6,000 consultants throughout North America, Europe and Asia and approximately $1 billion in annual business. The company partners with organizations to develop technology strategies and solutions that deliver tangible business value. Since its founding in 1974, the company has worked to deliver technical savvy and IT solutions to drive clients toward their strategic goals. For more information, visit the company’s website at

CNS Response, Inc. (CNSO)

CNS Response, Inc. (OTC MKTS: CNSO) provides clinicians and researchers in psychiatry with a unique set of reference data and analytic tools. The company’s Psychiatric EEG Evaluation Registry, or PEER Onine, is a new registry and reporting platform that allows medical professionals to exchange treatment data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). The company’s PEER Online is designed to help physicians avoid trial and error pharmacotherapy. For more information, visit the company’s website at

Consolidated Water Co. Ltd. (CWCO)

Consolidated Water Co. Ltd. (NASDAQ: CWCO) was established in 1973 as the largest private water utility in Grand Cayman, Cayman Islands. Today, the company develops and operates seawater desalination plants and water distribution systems in areas of the world where naturally occurring supplies of potable water are scarce or nonexistent. The company currently operates water production and distribution facilities in a variety of locales around the planet. For more information, visit the company’s website at

ContraVir Pharmaceuticals, Inc. (CTRV)

ContraVir Pharmaceuticals, Inc. (OTCQB: CTRV) is a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies. The company’s leading candidate, FV-100, is being developed for the treatment of shingles. Preclinical studies have demonstrated FV-100 as a significant improvement in potency as compared to currently available FDA-approved drugs. The company is planning a large trial to explore FV-100’s potential to treat long-term nerve pain typically associated with shingles. For more information, visit the company’s website at

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (OTCQB: CRBP) is a clinical stage pharmaceutical company focused on the development and commercialization of new therapeutics to treat rare, life-threatening inflammatory-fibrotic diseases with clear unmet medical needs. The company’s leading product candidate, Resunab, is a first-in-class oral anti-inflammatory drug currently scheduled to commence Phase II clinical trials for the treatment of cystic fibrosis and diffuse scleroderma later this year pending FDA approval of IND. For more information, visit the company’s website at

CPI Aerostructures, Inc. (CVU)

CPI Aerostructures, Inc. (NYSE MKT: CVU) is a U.S. manufacturer of structural assemblies for fixed wing aircraft, helicopters and airborne Intelligence Surveillance and Reconnaissance pod systems in both the commercial aerospace and national security markets. The company is a prime contractor to the U.S. Department of Defense, primarily the Air Force. In addition to assembly operations, the company provides engineering, program management, supply chain management and MRO services to its clients. For more information, visit the company’s website at

Cumulus Media, Inc. (CMLS)

Cumulus Media, Inc. (NASDAQ: CMLS) combines high-quality local programming with nationally syndicated media, sports and entertainment brands in order to deliver premium choices to listeners and provide substantial reach for advertisers. The company is the largest pure-play radio broadcaster in the United States with approximately 460 owned-and-operated stations in 90 markets, 9,000 broadcast radio affiliates and numerous digital channels. The company also owns a significant stake in the Rdio digital music service. For more information, visit the company’s website at

CÜR Media, Inc. (CURM)

CÜR Media, Inc. (OTCQB: CURM) is the company behind CÜR Music, a hybrid music streaming service planning to launch for mobile devices and the web in early 2015. The company describes its streaming service as an intersection between internet radio services and on-demand music services. The company began testing in early 2012 with a product called Radiataz, which had over 150,000 monthly beta users, before transitioning to an enhanced product. For more information, visit the company’s website at

Cynapsus Therapeutics, Inc. (CYNAF)

Cynapsus Therapeutics, Inc. (OTC MKTS: CYNAF) is a specialty pharmaceutical company developing sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease. The company’s leading drug candidate, APL-130277, is an easy-to-use, fast-acting formulation of apomorphine, which is the only drug approved in the United States to rescue patients from OFF episodes. The company is completing pivotal studies in advance of submitting a new drug application in 2016. For more information, visit the company’s website at

Datalink Corporation (DTLK)

Datalink Corporation (NASDAQ: DTLK) is a complete data center solution and services provider for Fortune 500 and mid-tier enterprises. The company works to transform data centers into more efficient, manageable and responsive solutions to account for changing business needs. The company helps leverage and protect storage, server and network investments with a focus on long-term value and a full lifecycle of services from consulting and design to implementation. For more information, visit the company’s website at

DATATRAK International, Inc. (DTRK)

DATATRAK International, Inc. (OTCQX: DTRK) is a worldwide technology and services company delivering unified eClincal ® solutions and related services for the clinical trials industry. The company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and authorities faster and more efficiently than loosely integrated technologies. The DATATRAK ONE ® software solution supports all phases of drug and device studies. For more information, visit the company’s website at

Digital Ally, Inc. (DGLY)

Digital Ally, Inc. (NASDAQ: DGLY) develops, manufactures and markets advanced technology products for law enforcement, homeland security and commercial security applications, primarily in the fields of digital video imaging and storage. The company has received state contracts and orders from law enforcement entities in all 50 states, as well as foreign countries and the U.S. military. Unique space-saving characteristics and cost-effectiveness of products have led to increased presence in law enforcement. For more information, visit the company’s website at

Diversicare Healthcare Services, Inc. (DVCR)

Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) is the owner and operator of 52 long-term skilled nursing and senior housing centers containing over 6,000 licensed beds. The company is recognized as a premier provider of post-acute care with services ranging from short-term rehabilitation for individuals recovering from an injury or illness to memory care programs for residents needing longer term care. The company strives to improve lives with exceptional healthcare and exceeded expectations. For more information, visit the company’s website at

Dot Hill Systems Corp. (HILL)

Dot Hill Systems Corp. (NASDAQ: HILL) leverages its proprietary Assured family of storage solutions to solve challenging storage problems while improving performance, increasing availability, simplifying operations and reducing costs. The company’s solutions combine breakthrough software with flexible hardware platforms and automated management to achieve best-in-class solutions to clients’ storage needs. The company currently has offices or representatives in seven countries around the globe including the U.S., China and Germany. For more information, visit the company’s website at

The E.W. Scripps Company (SSP)

The E.W. Scripps Company (NYSE: SSP) serves audiences and businesses through a growing portfolio of media brands. The company is currently the nation’s fifth largest broadcasting group, owning an expanding collection of local and national digital journalism and information businesses including mobile video news service Newsy and weather app developer Weathersphere. The company also runs an award-winning investigative reporting newsroom in Washington, D.C. and stewards the nation’s largest spelling bee. For more information, visit the company’s website at

Electro Scientific Industries, Inc. (ESIO)

Electro Scientific Industries, Inc. (NASDAQ: ESIO) uses integrated solutions to allow industrial designers and process engineers to control the power of laser light in order to transform materials in ways that differentiate their consumer electronics, wearable devices, semiconductor circuits and high-precision components for distinct market advantage. The company’s laser-based manufacturing solutions feature the micro-machining industry’s highest precision, as well as speed, and the lowest total cost of ownership. For more information, visit the company’s website at

Elephant Talk Communications Corp. (ETAK)

Elephant Talk Communications Corp. (NYSE MKT: ETAK) is a global provider of mobile proprietary Software Defined Network Architecture platforms for the telecommunications industry. The company provides a full suite of applications, superior industry expertise and high quality customer service to Mobile Network Operators (MNOs) and other operators without the need for substantial upfront investment. The company’s customer and partner list includes several of the world’s leading MNOs and technology companies. For more information, visit the company’s website at

Emergent Biosolutions, Inc. (EBS)

Emergent Biosolutions, Inc. (NYSE: EBS) is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Since its founding in 1998, the company’s focus has been upon innovation and growth to protect and enhance life. Beginning with a single location in Lansing, Michigan, the company now has multiple sites around the world. For more information, visit the company’s website at

Energy Fuels, Inc. (UUUU)

Energy Fuels, Inc. (NYSE MKT: UUUU) is America’s largest conventional uranium producer, which supplied approximately 20% of the uranium produced in the U.S. in 2014. The company operates the White Mesa mill, which is the only conventional uranium mill currently operating in the U.S. The company has projects located in a number of Western U.S. states, including a producing mine, mines on standby and mineral properties in various stages of development. For more information, visit the company’s website at

Engility Holdings, Inc. (EGL)

Engility Holdings, Inc. (NYSE: EGL) is a pure-play government services contractor providing highly skilled personnel to clients, wherever, whenever they are needed, in a cost-effective manner. The company is a leading provider of highly specialized technical consulting, program and business support services, engineering and technology lifecycle support, information technology modernization and sustainment, supply chain services and logistics management, and training and education for the U.S. government. For more information, visit the company’s website at

Entercom Communications Corp. (ETM)

Entercom Communications Corp. (NYSE: ETM) is one of the largest radio broadcasting companies in the United States. The company holds a nationwide portfolio of over 100 stations in 23 markets. The company’s radio stations have received numerous awards including Edward R. Murrow Awards for excellence in journalism. In 2012, the company was named as one of the Top 500 Technology Innovators in the United States by Information Week. For more information, visit the company’s website at

Entravision Communications Corp. (EVC)

Entravision Communications Corp. (NYSE: EVC) is a diversified media company serving Latino audiences and communities with an integrated platform of solutions and services that includes television, radio, digital media and data analytics to reach audiences across the United States and Latin America. The company owns and operates 58 primary television stations in 20 of the nation’s top 50 Latino markets, as well as 49 Spanish-language radio stations. For more information, visit the company’s website at

Enumeral Biomedical Holdings, Inc. (ENUM)

Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM) is discovering and developing new antibody immunotherapies that help the immune system attack diseased cells. The company relies on a unique ability to extensively interrogate the human immune microenvironment for candidate selection and validation in order to measure drug effects in a patient-specific manner. The company is building a pipeline of immunomodulators for the treatment of cancer and inflammatory diseases. For more information, visit the company’s website at

EPIQ Systems, Inc. (EPIQ)

EPIQ Systems, Inc. (NASDAQ: EPIQ) is a leading global provider of integrated technology solutions for legal professions, including electronic discovery, bankruptcy and class action and mass tort administration. The company also offers full-service capabilities to support litigation, investigations, financial transactions, regulatory compliance and other legal matters. The company’s global presence spans 45 countries served from 20 locations, allowing for secure, reliable solutions for the worldwide legal community. For more information, visit the company’s website at

Exactech, Inc. (EXAC)

Exactech, Inc. (NASDAQ: EXAC) develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. In addition to the United States, the company markets its products to more than 30 markets in Europe, Latin America, Asia and the Pacific. For more information, visit the company’s website at

Finjan Holdings, Inc. (FNJN)

Finjan Holdings, Inc. (NASDAQ: FNJN) owns a portfolio of patents related to software that proactively detects malicious code and protects end users from identity and data theft, spyware, malware, phishing, trojans and other online threats. The company’s mission is to invest in innovation and encourage the development of core intellectual property. The company’s patented technology is capable of detecting previously unknown and emerging threats on a real-time, behavior-based basis. For more information, visit the company’s website at

FluoroPharma Medical, Inc. (FPMI)

FluoroPharma Medical, Inc. (OTC MKTS: FPMI) is a biopharmaceutical company engaged in the development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The company’s initial focus is the development of breakthrough PET imaging agents, with two products advancing into clinical trials for assessment of acute and chronic forms of coronary artery disease. The company is also developing agents for imaging specific cancers. For more information, visit the company’s website at

Forrester Research, Inc. (FORR)

Forrester Research, Inc. (NASDAQ: FORR) is a global research and advisory firm serving professionals in 13 key roles across three distinct segments. The company provides proprietary research, consumer and business data, custom consulting, online events and communities, and peer-to-peer executive programs in order to help clients understand and act upon new opportunities. The company guides leaders in business technology, marketing and strategy, and the technology industry towards enhanced success. For more information, visit the company’s website at

Fusion Telecommunications International, Inc. (FSNN)

Fusion Telecommunications International, Inc. (NASDAQ: FSNN) is a leading provider of integrated cloud solutions to businesses of all sizes. The company’s advanced, proprietary cloud service platform enables the integration of leading edge solutions in the cloud, including cloud communications, cloud connectivity and cloud computing. The company’s innovative cloud solution presents customers with lower cost of ownership and new levels of security, flexibility, scalability and speed of deployment. For more information, visit the company’s website at

Galena Biopharma, Inc. (GALE)

Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. The company’s leading drug candidate, NeuVax™, is currently in an international, Phase III clinical trial. The company’s commercial drugs include Abstral® (fentanyl) Sublingual Tablets and Zuplenz® (ondansetron) Oral Soluble Film. The company’s strategy focuses on advancing therapeutic opportunities and improving cancer care. For more information, visit the company’s website at

Galmed Pharmaceuticals Ltd. (GLMD)

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a new, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones. The company uses its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates to improve the effectiveness of product candidates. The company’s leading product candidate, Aramchol, is being developed to serve as a disease modifying treatment for fatty liver disorders. For more information, visit the company’s website at

Gannett Company, Inc. (GCI)

Gannett Company, Inc. (NYSE: GCI) is an international media and marketing solutions company that informs and engages more than 110 million people every month through its powerful network of broadcast, digital, mobile and publishing properties. The company’s portfolio of brands offers marketers unmatched local-to-national reach and customizable marketing solutions across a wide variety of platforms. The company is committed to connecting people with their interests and communities. For more information, visit the company’s website at

GenSpera, Inc. (GNSZ)

GenSpera, Inc. (OTC MKTS: GNSZ) conceives, designs and develops curative cancer therapies that are core to the principles of extending human life. The company’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. The company’s leading drug candidate, Mipsagargin, is expected to have potential efficacy in a wide variety of tumor types. For more information, visit the company’s website at

GreenHunter Resources, Inc. (GRH)

GreenHunter Resources, Inc. (NYSE MKT: GRH) provides Total Water Management Solutions™/Oilfield Fluid Management Solutions™ in the oilfield and its shale plays of the Appalachian Basin through its wholly-owned subsidiaries. GreenHunter Water, LLC, a subsidiary of the company, continues to expand its services package by increasing down-hole injection capacity. GreenHunter Environmental Solutions, LLC, another subsidiary of the company, offers onsite environmental solutions at the well pad and facilities for waste stream management. For more information, visit the company’s website at

Guardian 8 Holdings (GRDH)

Guardian 8 Holdings (OTC MKTS: GRDH) is the developer and manufacturer of the Pro V2, an enhanced non-lethal response to threats that revolutionizes how companies keep workplaces safe and mitigate risk. The Pro V2 provides its operator with non-lethal means to protect themselves and others while allowing time for law enforcement response. The company was awarded the “Campus Safety BEST Award” for 2014 in the personal gear and equipment category. For more information, visit the company’s website at

Guidance Software, Inc. (GUID)

Guidance Software, Inc. (NASDAQ: GUID) is the industry leader in endpoint investigation solutions for security incident response and analysis. The company’s EnCase® Enterprise platform is used by more than 70 percent of the Fortune 100 and numerous government agencies to conduct digital investigations of servers, laptops, desktops and mobile devices. The company’s electronic discovery solutions empower organizations to conduct speedy and thorough security incident response and respond to litigation discovery requests. For more information, visit the company’s website at


For more frequent updates, follow us on Twitter!

Home     About Us     IR Services     Investors     Partners     Market Research     Blog     Contact     Disclaimer

© 2015 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975